Finance

Lists
PRGO:NYSE
Perrigo Company PLC
14,44 USD
+1,30%
(+0,18) 1D
14,44 USD
0,00% (0,00)
After hours
Closed: 5-окт., 16:00:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRGO...
Open
14,20 USD
High
14,58 USD
Low
14,02 USD
Mkt. cap
2,00 млд
Avg. vol.
2,80 млн
Volume
1,88 млн
Dividend
8,03%
Quarterly dividend
0,29 USD
Ex-dividend date
2026-ж., 28-авг.
52-wk high
22,48 USD
52-wk low
9,22 USD
EPS
-12,59 USD
Beta
0,67
Shares outstanding
138,77 млн
No. of employees
8 миң
Open
14,20 USD
High
14,58 USD
Low
14,02 USD
Mkt. cap
2,00 млд
Avg. vol.
2,80 млн
Volume
1,88 млн
Dividend
8,03%
Quarterly dividend
0,29 USD
Ex-dividend date
2026-ж., 28-авг.
52-wk high
22,48 USD
52-wk low
9,22 USD
EPS
-12,59 USD
Beta
0,67
Shares outstanding
138,77 млн
No. of employees
8 миң
News stories
From web sources and news partners
Profile
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
About Perrigo Company PLC
CEOMurray S. Kessler
Employees8,1 миң
Founded1887
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 1 analyst giving stock ratings to PRGO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for PRGO in the last 3 months
Highest
Current 14,44 USD
17,00 USD (+17,73%)
Average
17,00 USD (+17,73%)
Lowest
17,00 USD (+17,73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Susan Anderson
Canaccord Genuity
Buy
Maintained
17,00 USD
+17,7%
08/12/2026
Christine Dooley
Argus Research
Hold
Maintained
-
-
05/19/2026
Chris Schott
J.P. Morgan
Hold
Maintained
15,00 USD
+3,9%
02/27/2026
Keith Devas
Jefferies
Hold
Maintained
23,00 USD
+59,3%
10/27/2025
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
EPS / Est. (USD)
0,50 USD / 0,36 USD
+40,85%beat
Revenue / Est. (USD)
1,02 млд / 1,01 млд
+1,25%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,04 млд
1,11 млд
969,20 млн
1,02 млд
Cost of goods sold
666,20 млн
747,40 млн
643,70 млн
708,90 млн
Cost of revenue
666,20 млн
747,40 млн
643,70 млн
708,90 млн
Research and development expenses
24,90 млн
21,80 млн
24,60 млн
23,70 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
245,70 млн
255,60 млн
267,30 млн
251,20 млн
Operating expense
283,50 млн
249,00 млн
291,90 млн
274,60 млн
Total operating expenses
949,70 млн
996,40 млн
935,60 млн
983,50 млн
Operating income
93,60 млн
113,20 млн
33,60 млн
39,30 млн
Other non operating income
300,00 миң
-10,70 млн
3,70 млн
10,10 млн
EBT including unusual items
22,40 млн
-1,33 млд
-408,60 млн
105,50 млн
EBT excluding unusual items
43,20 млн
68,70 млн
-1,30 млн
-8,50 млн
Income tax expense
9,70 млн
82,90 млн
-18,70 млн
16,90 млн
Effective tax rate
43,30%
-6,23%
4,58%
16,02%
Other operating expenses
12,90 млн
-28,40 млн
-
-300,00 миң
Net income
7,50 млн
-1,42 млд
-398,60 млн
74,50 млн
Net profit margin
0,72%
-127,80%
-41,13%
7,28%
Earnings per share
0,80
0,77
0,43
0,50
Interest and investment income
-
-
-
-
Interest expense
-50,10 млн
-52,80 млн
-49,00 млн
-47,00 млн
Net interest expenses
-50,10 млн
-52,80 млн
-49,00 млн
-47,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
179,00 млн
199,10 млн
116,90 млн
116,20 млн
Gain or loss from assets sale
-
-
-
-129,50 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору